A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

The trial is anticipated to enrol 462 subjects and aims to confirm the safety and efficacy of the combination.

The company expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024, and the ...

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.

Scientists have discovered that the Brazilian camu-camu berry, already known for its health benefits in fighting obesity and ...

Atezolizumab (Tecentriq) plus chemotherapy after surgery did not improve survival in high-risk triple-negative breast cancer, according to a global phase 3 trial.

PHOTO PROVIDED Members of Post 623’s Sons of the American Legion (SAL) in Beech Creek, Pa., presented a check to Wendy ...

If you have metastatic breast cancer, you may need help from loved ones and your medical team along the way. Here’s how to ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...